Dynamic CtDNA-guided Targeted Therapy in DLBCL

Clinical trial NCT06748521 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06748521
Sponsor: Ruijin Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma (DLBCL)

Start date: 2024-12-31
Primary completion: 2026-12-13
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.